🇺🇸 FDA
Patent

US 6555127

Multi-spike release formulation for oral drug delivery

expired A61KA61K9/0007A61K9/0056

Quick answer

US patent 6555127 (Multi-spike release formulation for oral drug delivery) held by Pharmaceutical Discovery Corporation expires Mon Apr 24 2023 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Pharmaceutical Discovery Corporation
Grant date
Tue Apr 29 2003 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 24 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K9/0007, A61K9/0056, A61K9/5084